Drug Consumption Rooms Worldwide

Similar documents
Evidence-based interventions for managing illicit drug dependence

The impact of economic recession on drug users and drug treatment

Chad Sabora, BS, MS, JD Missouri Network for Opiate Reform and Recovery. Drug Policy, Harm Reduction, and What s Next

Feasibility study on drug consumption rooms in Belgium (DRUGROOM) Summary

The forgotten group: a new HIV outbreak amongst people who inject drugs. Patricia Anderson Lead CNS BBV Brownlee Centre

SAN FRANCISCO SAFE INJECTION SERVICES TASK FORCE

Strategies of drug users to avoid infection with hepatitis C

HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications

New trends in harm reduction in Europe: progress made challenges ahead

EMCDDA-update HIV/HCV among people who inject drugs: situation and response

Overview of drug-induced deaths in Europe - What does the data tell us?

Palliative nursing care of children and young people across Europe

Injecting trends in Austria including results of a systematic literature review on interventions aiming to influence the route of administration

Frequently Asked Questions about Supervised Injecting Facilities 24 July 2014

Authors: Jennifer Kates (Kaiser Family Foundation), Eric Lief (The Stimson Center), Carlos Avila (UNAIDS).

HIV/AIDS Think Tank meeting: EMCDDA report. Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015

Innovative approaches for preventing infection with hepatitis c among drug users

ANNUAL PROJECT PROGRESS REPORT FOR 2008 (draft)

The Comprehensive Package: The simple truth about our response to drug related HIV. Dr. Monica Beg, Signe Rotberga UNODC

Smokefree Policies in Europe: Are we there yet?

Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2011

WCPT COUNTRY PROFILE December 2017 SWEDEN

Services and Support Information Leaflet

WCPT COUNTRY PROFILE December 2017 HUNGARY

HARM REDUCTION SERVICES IN SAN FRANCISCO

WCPT COUNTRY PROFILE December 2017 SERBIA

Online census of Drug Consumption Rooms (DCRs) as a setting to address HCV: current practice and future capacity

Good Laboratory Practice. EU-Serbia screening meeting Brussels, 19 June 2014

GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy

Integrated harm reduction services for drug users and homeless people. Katrin Schiffer

PERSPECTIVES ON DRUGS Drug consumption rooms: an overview of provision and evidence

State of provision of Hearing Aids in Europe

Recent trends in drug problems and service provision in Greece

Public drug policies Catalonia

Authors: Jennifer Kates (Kaiser Family Foundation), José-Antonio Izazola (UNAIDS), Eric Lief (CSIS).

Key Highlights continued

Implementing the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2010 Progress Report SPECIAL REPORT.

Financing the Response to AIDS in Low- and Middle- Income Countries: International Assistance from Donor Governments in 2010

Taking away the chaos The health needs of people who inject drugs in public places in Glasgow city centre

Where we stand in EFORT

Supervised Injection Services: Evidence and Practice

Research paper: Legal treatment of the use of cannabis for medical purposes in the member states of the European Union

508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender

INTRAVENOUS INJECTING DRUG USE.

Tajikistan National Report. Summary HARM REDUCTION WORKS FUND IT! Arguments for strategic investment. Summary of National Report: Tajikistan

Project Meeting Prague

Media Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences

Strategies to enhance HCV testing, linkage to care and treatment

26 28 May 2010, Almaty, Kazkhstan. Nina Kerimi UNODC Regional Project Coordinator 1

Hepatitis C Strategy. About us. What is hepatitis C?

Allied Health: Sustainable Integrated Health Care for all Australians

Becoming a harm reduction distribution agency in Toronto - information session

Monitoring harm reduction implementation in European prisons: public health and human rights approaches

Donor Government Funding for HIV in Low- and Middle-Income Countries in 2016

EMCDDA looks behind rising numbers of young people in cannabis treatment

Statement by the Portuguese Deputy Minister for Health. Vienna, 8 March 2010

Joint Action on HIV and co-infection prevention and harm reduction HA-REACT

OST saves lives it s official! OST a key to HIV prevention Opioid Substitution Treatment in Germany A Story of Success

Harm Reduction in Nigeria

Technical Guidance Note for Global Fund HIV Proposals

Feedback from joint country mission on HIV and hepatitis B and C of ECDC and EMCDDA experts to Latvia, September 2014

Identifying local harm reduction priorities: involving drug users and professionals

Europa Donna in Europe and in Slovenia

Thomas Karlsson & Esa Österberg National Research and Development Centre for Welfare and Health Alcohol and Drug Research Group P.O.

Drug Use, Harm Reduction, and HIP

HIV/AIDS Prevention, Treatment and Care among Injecting Drug Users and in Prisons

Building a european consensus on minimum quality standards for drug treatment, rehabilitation and harm reduction

Mid-term Review of the UNGASS Declaration of. Commitment on HIV/AIDS. Ireland 2006

CND UNGASS FOLLOW UP

WESTERN EUROPE PREVALENCE AND INCIDENCE OF PERIPHERAL ARTERY DISEASE AND CRITICAL LIMB ISCHEMIA 2017

Trends in injecting drug use in Europe

Improving NSP and Harm Reduction Services. Jason Farrell, European HCV and Drug Use Initiative

Treatment and Harm Reduction in Prisons. Republic of Moldova

Civil Society Driven Response in Ukraine: A program making a difference and bringing results

HIV AND PEOPLE WHO INJECT DRUGS

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

The role of UNODC in working law enforcement agencies to promote harm reduction. IHRC, Bangkok, 23 April 2009

Clinical Evidence in the Daily Work of an Anthroposophic Hospital Dr. med. Harald Matthes, Medical Director, Havelhöhe Hospital in Berlin

COUNTRY TABLE. MONTENEGRO.

UNAIDS 99.1E (English original, March 1999) This document, presenting a speech given at the United Nations General Assembly Special Session on Drugs,

Harm reduction among drug users in Spain

European status report on alcohol and health Leadership, awareness and commitment

Co-ordination, monitoring and evaluation of drug policies. Bob Keizer. Senior Drug Policy Advisor. Trimbos-instituut

The current status of PrEP in Europe. Pep Coll AIDS Research Institute-IrsiCaixa Fight AIDS Foundation BCN Checkpoint

Prevention Point Philadelphia

Questions & Answers. What are the risks associated with consumption drug use?

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID

DRUGSCOPE MANIFESTO European Parliament Elections 2004: Next steps for European drug policy

ATLAS on substance use 2017:

CLL Patient Voices Survey Final Report. PHEM/DAT/0418/0008 May 2018

Service Model: For Non-Clinical and Clinical Settings: HIV Testing. Agencies may employ evidence-based strategies, including the social network

United Nations Population Fund

Most recent data, analyses and feed-back from the 2016 DRID national updates

Transcription:

Drug Consumption Rooms Worldwide Eberhard Schatz Correlation Network International Network of Drug Consumption Rooms

Introduction Overview of the current state of DCR s worldwide Presentation of the INDCR Network

9 Drop-In centres 4 Drug consumption rooms > was 6 1 Alcohol consumption room (HR Programme) >closed 2 Needle exchange programmes Psycho-social support Activation programmes and labor projects Buddy projects Volunteers International work

Improve access and quality of health and social services for marginalised groups European network since 2004 More than 180 partners in all European countries Hepatitis C Initiative since 2014 Host of the International Network of Drug Consumption Rooms

International Network of Drug Consumption Rooms

History of DCR s HIV/AIDS epidemic begin '80 Harm Reduction Experiments in the Netherlands, Germany, Switzerland by the end of 1980 1986 Switzerland, 1992 Germany 1998 the Netherlands Begin 2000 Canada, Australia, Norway, Luxemburg, Spain Lately Denmark, 2016 France Serious efforts in Greece, Slovenia,, Italy, Portugal, Belgium Comming: USA, Ireland

Legal Aspects national legislation > pilot projects international legislation United Nations International Narcotics Control Board (INCB) United Nations Office on Drugs and Crime (UNODC) European Drug Strategy

Legal Aspects National: A DCR operates within the legal system of the particular country in which it has been established, either as an independent legal entity, as a unit of a healthcare facility, as a non-governmental organisation (NGO), which is very common, or as part of a local governmental or public health service. In most countries, it has been necessary to modify specific laws in order to decriminalise drug consumption in the DCRs. International: The International Narcotics Control Board (INCB), the UN body responsible for monitoring the implementation of the UN drug conventions has repeatedly expressed its concerns regarding the development of DCRs but changed position in 2016. The United Nations Office on Drugs and Crime (UNODC) came to the conclusion in 2002 that many interventions, including DCRs, were not contrary to the conventions. The European Drug Strategy, a not binding recommendation, expresses favor for a comprehensive, well balanced drug policy including measures like drug consumption rooms.

Methods Integrated DCRs are part of a wider network of services for people who use drugs. The drug consumption room provides an important additional component of services alongside services like OST, drop in centres and counselling. Specialist DCRs focus on protected places for hygienic consumption of drugs in a non-judgmental environment. They are usually set up close to other drugs services and located near open drug scenes. They can refer to other services. Mobile DCRs are specially fitted out vans with 1 3 injections booths inside. Mobile DCRs avoid the risk of making one building the focus of all activities and they can reach people where they are. DCRs for women/housing projects and shelters

Publications

DCRs Country overview Social functions Country Total No. of No. of cities Surveyed DCRs DCRs with DCR Denmark 5 3 4 Germany 24 15 16 Greece 1 1 0 Luxembourg 1 1 1 Netherlands 30 23 n.a. Norway 1 1 1 Spain 13 6 5 Switzerland 13 8 12 Total 88 58 39 What social functions does your DCR fulfil? Sweeper 22 64.7% Safety net 32 94.1% Spring board 31 91.2% All of the above 20 58.8%

Visitors per day

DCR services DCR SERVICES Europe (2013) Netherlands (2010) Bread, coffee/tea 87.5% 97% Warm meals 62.5% 83% Needle exchange 100% 93% Provision of drug paraphernalia 96.9% 100% Personal care (e.g. shower and wash clothes) 78.1% 90% Lockers 31.3% 57% Postal address 46.9% 40% Possibility to use phone 90.6% 87% Support with financial and administrative affairs 81.3% 77% Health education 100% 90% Office hours physician 59.4% 63% Office hours nurse 84.4% 57% Referral to care/treatment facilities 87.5% 93% Work/reintegration projects 28.1% 73% Referral to work/reintegration projects elsewhere 65.6% 77% Recreational activities 40.06% 67%

1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 What year did the DCR open to users? [n=44] 8 7 6 5 4 3 2 1 0 no. of DCRs that opened

DCR services

Can you tell us about your clients and service data (e.g. 50% of men; 2% HIV positive etc)? 90,0 80,0 82 80 80 70,0 71 70 70 60,0 57 60 50,0 40,0 30,0 39 33,5 20,0 15 10,0 6 0,0 % men (n=40) % HCV (n=41) % ever in treatment (n=17) % in opioid substitution therapy (n=27) % homeless (n=32) % HIV positive (n=28)

DCR services

DCR services

DCR services

DCR services

DCR services

HCV prevention & transmission routes HCV testing HCV infection symptoms HCV treatment options We don't provide any HCV information Questions in regard of HCV awareness Does your DCR provide education about the following? [multiple response, n=49] 100% 90% 80% 70% 60% 50% 40% 30% 94% 78% 76% 76% 20% 10% 0% 6%

Does your DCR provide HCV testing ONSITE (by your staff or by external agency, n=49)? 2% 33% Yes No Don't know 65% Does your DCR provide HCV treatment ONSITE (by staff or by external agency, n=48)? 4% 4% 8% No Yes, new HCV treatment forms (DAAs) Yes, both treatment options 83% Don't know

DCR services

DCR services

Geschiedenis

Geschiedenis

Geschiedenis

Is there evidence that DCR s are effective? EMCDDA, PERSPECTIVES ON DRUGS Drug consumption rooms: an overview of provision and evidence 2016 the benefits of providing supervised drug consumption facilities may include improvements in safe, hygienic drug use, especially among regular clients, increased access to health and social services, and reduced public drug use and associated nuisance. There is no evidence to suggest that the availability of safer injecting facilities increases drug use or frequency of injecting. These services facilitate rather than delay treatment entry and do not result in higher rates of local drug-related crime.

Discussion evidence vs political and ideological priorities public nuisance and health protection cost effectiveness in times of crisis participation and user involvement